NCT01727063View on ClinicalTrials.gov

Cell Therapy in Severe Chronic Ischemic Heart Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Chronic Ischemic Heart DiseaseCoronary Artery DiseaseAngina Pectoris
Interventions
PROCEDURE

Cell Therapy

Intramyocardial injection of autologous bone marrow-derived cells

Trial Locations (1)

05403-000

Heart Institute, São Paulo

All Listed Sponsors
lead

Ministry of Health, Brazil

OTHER_GOV

NCT01727063 - Cell Therapy in Severe Chronic Ischemic Heart Disease | Biotech Hunter | Biotech Hunter